New spectacle lens aims to halt myopia in teenagers
NCT ID NCT05818033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested whether a specially designed spectacle lens (CARE1.02) can slow the progression of myopia (nearsightedness) in teenagers aged 12 to 17. About 796 teens in Guangzhou, China, wore either the CARE1.02 lens or a standard single-vision lens for one year. Researchers measured changes in eye prescription and eye length to see if the new lens worked better at controlling myopia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CARE1.02 spectacle lens (a specially designed lens to slow myopia progression)
- What this could lead to
- If it works, this could offer a new, non-invasive option to slow down worsening nearsightedness in teenagers.
- What could go wrong
- The trial is completed but results are not yet widely known. The effect may be modest, and not all teens may benefit equally.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart glasses aim to stop nearsightedness before it starts
- Can a pair of glasses slash motorcycle crashes?
- Virtual streets could shape Kids' vision and feelings
- Can a new lens design improve overnight vision correction?
- Ear seeds and smart glasses: a new hope to halt childhood myopia?
- Red light therapy for nearsighted kids: what happens when it stops?